The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiplatform profiling of pancreatic neuroendocrine tumors (PanNETs) identifies novel co-occurring pathogenic alterations and associations with clinicopathologic factors.
 
Michelle Guan
Research Funding - Halozyme (Inst)
 
Jun Gong
No Relationships to Disclose
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Ipsen; Novartis; Perthera; Xbiotech
Travel, Accommodations, Expenses - Halozyme
 
Richard Tuli
No Relationships to Disclose
 
Veronica Placencio-Hickok
Patents, Royalties, Other Intellectual Property - Cedars-Sinai Medical Center
 
Joseph Bender
Employment - Perthera
 
Edik Matthew Blais
Employment - Perthera
Stock and Other Ownership Interests - Perthera
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Avant Diagnostics; Ceres Nanosciences; Perthera
Consulting or Advisory Role - Avant Diagnostics; AZGen; Ceres Nanosciences; Perthera
Research Funding - Abbvie (Inst); Ceres Nanosciences (Inst); GlaxoSmithKline (Inst); Symphogen (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera